Health
Model simulations show no need for DEX dose adjustments in COVID-19 patients with liver disease – News-Medical.net
A recent study sed PBPK modeling to demonstrate the use of DEX PKs for the treatment of COVID-19 in patients with liver impairment….
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, in December 2019. Studies have shown that between 3% to 8% of coronavirus disease 2019 (COVID-19) patients have pre-existing chronic liver disease (LD)….
-
Noosa News23 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Noosa News23 hours agoAfter Hours Gallery Visits, French Dining and Garden Illuminations: Your Guide to the Ultimate Melbourne Culture Fix
-
General16 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Business16 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?